Raymond W Cohen - Net Worth and Insider Trading

Raymond W Cohen Net Worth

The estimated net worth of Raymond W Cohen is at least $13 Million dollars as of 2024-04-30. Raymond W Cohen is the CEO of Axonics Inc and owns about 188,835 shares of Axonics Inc (AXNX) stock worth over $13 Million. Raymond W Cohen is the Director of BioLife Solutions Inc and owns about 22,763 shares of BioLife Solutions Inc (BLFS) stock worth over $403,816. Raymond W Cohen is also the Director of Spectrum Pharmaceuticals Inc and owns about 28,850 shares of Spectrum Pharmaceuticals Inc (SPPI) stock worth over $29,716. Details can be seen in Raymond W Cohen's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Raymond W Cohen has not made any transactions after 2024-01-31 and currently still holds the listed stock(s).

Transaction Summary of Raymond W Cohen

To

Raymond W Cohen Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Raymond W Cohen owns 3 companies in total, including BioLife Solutions Inc (BLFS) , Axonics Inc (AXNX) , and Spectrum Pharmaceuticals Inc (SPPI) .

Click here to see the complete history of Raymond W Cohen’s form 4 insider trades.

Insider Ownership Summary of Raymond W Cohen

Ticker Comapny Transaction Date Type of Owner
BLFS BioLife Solutions Inc 2020-11-12 director
AXNX Axonics Inc 2024-01-31 director & Chief Executive Officer
SPPI Spectrum Pharmaceuticals Inc 2018-05-14 director

Raymond W Cohen Latest Holdings Summary

Raymond W Cohen currently owns a total of 3 stocks. Among these stocks, Raymond W Cohen owns 188,835 shares of Axonics Inc (AXNX) as of January 31, 2024, with a value of $13 Million and a weighting of 96.67%. Raymond W Cohen owns 22,763 shares of BioLife Solutions Inc (BLFS) as of November 12, 2020, with a value of $403,816 and a weighting of 3.1%. Raymond W Cohen also owns 28,850 shares of Spectrum Pharmaceuticals Inc (SPPI) as of May 14, 2018, with a value of $29,716 and a weighting of 0.23%.

Latest Holdings of Raymond W Cohen

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AXNX Axonics Inc 2024-01-31 188,835 66.67 12,589,629
BLFS BioLife Solutions Inc 2020-11-12 22,763 17.74 403,816
SPPI Spectrum Pharmaceuticals Inc 2018-05-14 28,850 1.03 29,716

Holding Weightings of Raymond W Cohen


Raymond W Cohen Form 4 Trading Tracker

According to the SEC Form 4 filings, Raymond W Cohen has made a total of 20 transactions in Axonics Inc (AXNX) over the past 5 years, including 1 buys and 19 sells. The most-recent trade in Axonics Inc is the sale of 35,161 shares on January 31, 2024, which brought Raymond W Cohen around $2 Million.

According to the SEC Form 4 filings, Raymond W Cohen has made a total of 5 transactions in BioLife Solutions Inc (BLFS) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in BioLife Solutions Inc is the sale of 5,625 shares on November 12, 2020, which brought Raymond W Cohen around $182,531.

According to the SEC Form 4 filings, Raymond W Cohen has made a total of 0 transactions in Spectrum Pharmaceuticals Inc (SPPI) over the past 5 years. The most-recent trade in Spectrum Pharmaceuticals Inc is the sale of 9,275 shares on May 14, 2018, which brought Raymond W Cohen around $169,918.

Insider Trading History of Raymond W Cohen

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Raymond W Cohen Trading Performance

GuruFocus tracks the stock performance after each of Raymond W Cohen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Raymond W Cohen is -24.82%. GuruFocus also compares Raymond W Cohen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Raymond W Cohen within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Raymond W Cohen's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Raymond W Cohen

Average Return

40.36%

Average return per transaction

Outperforming Transactions

100%

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 15.87 -24.82 -2.47 40.36 50.17 32.07
Relative Return to S&P 500(%) 12.51 -31.59 -18.57 24.19 26.13 19.19

Raymond W Cohen Ownership Network

Ownership Network List of Raymond W Cohen

No Data

Ownership Network Relation of Raymond W Cohen


Raymond W Cohen Owned Company Details

What does BioLife Solutions Inc do?

Who are the key executives at BioLife Solutions Inc?

Raymond W Cohen is the director of BioLife Solutions Inc. Other key executives at BioLife Solutions Inc include VP & Global Human Resources Sarah Aebersold , Chief Tech. Officer & Sr. VP Aby J. Mathew , and Vice President & Marketing Todd Berard .

BioLife Solutions Inc (BLFS) Insider Trades Summary

Over the past 18 months, Raymond W Cohen made no insider transaction in BioLife Solutions Inc (BLFS). Other recent insider transactions involving BioLife Solutions Inc (BLFS) include a net sale of 162,286 shares made by Aby J. Mathew , a net sale of 48,159 shares made by Todd Berard , and a net sale of 16,114 shares made by Karen A. Foster .

In summary, during the past 3 months, insiders sold 73,911 shares of BioLife Solutions Inc (BLFS) in total and bought 0 shares, with a net sale of 73,911 shares. During the past 18 months, 530,204 shares of BioLife Solutions Inc (BLFS) were sold and 1,135,630 shares were bought by its insiders, resulting in a net purchase of 605,426 shares.

BioLife Solutions Inc (BLFS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

BioLife Solutions Inc Insider Transactions

No Available Data

Raymond W Cohen Mailing Address

Above is the net worth, insider trading, and ownership report for Raymond W Cohen. Currently GuruFocus does not have mailing address information for Raymond W Cohen.

Discussions on Raymond W Cohen

No discussions yet.